Development and validation of an interpretable prediction model for high-grade vesicoureteral reflux in children with urinary tract infections.

IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2026-10-02 eCollection Date: 2026-01-01 DOI:10.3389/fmed.2026.1864622
Le-Zhen Ye, Jian-Xin Sun, Jing Chen, Jin-Liang Chen, Ye Bi, Yan-Ru Zhang
{"title":"Development and validation of an interpretable prediction model for high-grade vesicoureteral reflux in children with urinary tract infections.","authors":"Le-Zhen Ye, Jian-Xin Sun, Jing Chen, Jin-Liang Chen, Ye Bi, Yan-Ru Zhang","doi":"10.3389/fmed.2026.1864622","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>High-grade vesicoureteral reflux (VUR) is prone to causing adverse clinical outcomes such as kidney damage, recurrent urinary tract infections, and hypertension. Early identification of the risk of developing high-grade VUR in children with urinary tract infections is of great significance for reducing unnecessary voiding cystourethrography (VCUG), guiding clinical decisions, and optimizing antibiotic management strategies.</p><p><strong>Methods: </strong>A total of 434 children with urinary tract infections who completed VCUG examination were retrospectively enrolled in this study. They were randomly divided into a training set (<i>n</i> = 304) and a test set (<i>n</i> = 130) in a 7:3 ratio. LASSO regression was used for feature selection. Based on the selected features, six machine learning prediction models were constructed: Logistic Regression, Random Forest, XGBoost, Gradient Boosting Machine, Elastic Net, and Support Vector Machine. The performance of the models was comprehensively evaluated using the area under the curve (AUC), integrated calibration index (ICI), precision-recall curve (PR), and decision curve analysis (DCA). Feature importance was ranked and explained using SHAP values.</p><p><strong>Results: </strong>Among the 434 patients, 156 individuals (35.9%) were diagnosed with grade ≥ 3 VUR. Seven predictive features were identified: delayed treatment response, annual UTI episodes, hydronephrosis, abnormal renal signal on MRU, febrile UTI (fUTI)/UTI ratio, age at first UTI, and non-Escherichia coli UTI episodes. Discrimination performance was comparable across the six models (test AUC range: 0.810-0.832; all pairwise DeLong tests <i>p</i> > 0.05); XGBoost was selected as the final model based on its good calibration (ICI=0.074) and consistent clinical net benefit, achieving a test AUC of 0.832 (95% CI: 0.757-0.897). Decision curve analysis showed that the model provided net benefits across threshold probabilities ranging from 0.15 to 0.90.</p><p><strong>Conclusions: </strong>We developed and validated a prediction model based on XGBoost, which can be used to assess the risk of high-grade vesicoureteral reflux in children with urinary tract infections. This model has good discrimination, acceptable calibration, and considerable clinical application potential. Additionally, based on this model, we developed and deployed a free online calculator at https://vur-prediction.yezhiqiu.cn, which can assist in real-time individualized risk assessment.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1864622"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672018/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1864622","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: High-grade vesicoureteral reflux (VUR) is prone to causing adverse clinical outcomes such as kidney damage, recurrent urinary tract infections, and hypertension. Early identification of the risk of developing high-grade VUR in children with urinary tract infections is of great significance for reducing unnecessary voiding cystourethrography (VCUG), guiding clinical decisions, and optimizing antibiotic management strategies.

Methods: A total of 434 children with urinary tract infections who completed VCUG examination were retrospectively enrolled in this study. They were randomly divided into a training set (n = 304) and a test set (n = 130) in a 7:3 ratio. LASSO regression was used for feature selection. Based on the selected features, six machine learning prediction models were constructed: Logistic Regression, Random Forest, XGBoost, Gradient Boosting Machine, Elastic Net, and Support Vector Machine. The performance of the models was comprehensively evaluated using the area under the curve (AUC), integrated calibration index (ICI), precision-recall curve (PR), and decision curve analysis (DCA). Feature importance was ranked and explained using SHAP values.

Results: Among the 434 patients, 156 individuals (35.9%) were diagnosed with grade ≥ 3 VUR. Seven predictive features were identified: delayed treatment response, annual UTI episodes, hydronephrosis, abnormal renal signal on MRU, febrile UTI (fUTI)/UTI ratio, age at first UTI, and non-Escherichia coli UTI episodes. Discrimination performance was comparable across the six models (test AUC range: 0.810-0.832; all pairwise DeLong tests p > 0.05); XGBoost was selected as the final model based on its good calibration (ICI=0.074) and consistent clinical net benefit, achieving a test AUC of 0.832 (95% CI: 0.757-0.897). Decision curve analysis showed that the model provided net benefits across threshold probabilities ranging from 0.15 to 0.90.

Conclusions: We developed and validated a prediction model based on XGBoost, which can be used to assess the risk of high-grade vesicoureteral reflux in children with urinary tract infections. This model has good discrimination, acceptable calibration, and considerable clinical application potential. Additionally, based on this model, we developed and deployed a free online calculator at https://vur-prediction.yezhiqiu.cn, which can assist in real-time individualized risk assessment.

尿路感染儿童高级别膀胱输尿管反流可解释预测模型的建立和验证
目的:高级别膀胱输尿管反流(VUR)易引起肾损害、复发性尿路感染、高血压等不良临床结局。早期识别尿路感染患儿发生高级别VUR的风险,对于减少不必要的排尿膀胱尿道造影(VCUG),指导临床决策,优化抗生素管理策略具有重要意义。方法:对434例完成VCUG检查的尿路感染患儿进行回顾性研究。按7:3的比例随机分为训练集(n = 304)和测试集(n = 130)。采用LASSO回归进行特征选择。基于选择的特征,构建了逻辑回归、随机森林、XGBoost、梯度增强机、弹性网和支持向量机6种机器学习预测模型。采用曲线下面积(AUC)、综合校准指数(ICI)、精确召回率曲线(PR)和决策曲线分析(DCA)对模型的性能进行综合评价。使用SHAP值对特征重要性进行排序和解释。结果:在434例患者中,156例(35.9%)被诊断为≥3级VUR。确定了七个预测特征:治疗反应延迟、每年尿路感染发作、肾积水、MRU肾信号异常、发热性尿路感染(fUTI)/尿路感染比率、首次尿路感染的年龄和非大肠杆菌尿路感染发作。6个模型的鉴别性能具有可比性(检验AUC范围:0.810-0.832;所有两两DeLong检验p < 0.05);基于良好的校准(ICI=0.074)和一致的临床净效益,选择XGBoost作为最终模型,测试AUC为0.832 (95% CI: 0.757-0.897)。决策曲线分析表明,该模型提供的净效益在阈值概率范围从0.15到0.90之间。结论:我们建立并验证了基于XGBoost的预测模型,该模型可用于评估尿路感染儿童发生高级别膀胱输尿管反流的风险。该模型判别性好,校正可接受,具有较大的临床应用潜力。此外,在此模型的基础上,我们开发并部署了一个免费的在线计算器https://vur-prediction.yezhiqiu.cn,它可以帮助实时个性化的风险评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书